CRB Monitor Securities Database Updates
During the week of January 9 - 15, 2023, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of January 9 - 15, 2023:
|
Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
|
Tier 1A |
152 |
128 / 22 / 2 |
+0 | -0 | +0 |
|
Tier 1B |
725 |
589 / 134 / 2 |
+0 | -0 | +0 |
|
Tier 2 |
353 |
328 / 22 / 3 |
+0 | -1 | -1 |
|
Tier 3 |
515 |
486 / 28 / 1 |
+1 | -0 | +1 |
|
Total Issuances |
1,745 |
1,531 / 206 / 8 |
+1 | -1 | +0 |
|
Total Issuers (w/o Pre-IPOs) |
1,340 |
- |
+0 | -0 | +0 |
|
Total Issuers (w/ Pre-IPOs) |
1,350 |
- |
+0 | -0 | +0 |
- Removed 1 Tier 2 Security:
- -1 = CRB Tier Downgraded to Tier 3: (“Scopus BioPharma Inc.”)
- Added 1 Tier 3 Security:
- +1 = CRB Tier Downgraded to Tier 3: (“Scopus BioPharma Inc.”)
- Rationale = There is no evidence to suggest that the company directly or indirectly (1) holds a cannabis license and/or (2) engages in "plant-touching" operations. Additionally, the company's involvement in the cannabis industry does not constitute a substantial revenue source, relative to its overall business. Therefore, qualifies for Tier 3.
- +1 = CRB Tier Downgraded to Tier 3: (“Scopus BioPharma Inc.”)
All newly-identified CRBs during the week:
|
Company Name |
Tier |
Pure-Play | Sector |
Description |
| N/A | N/A | N/A | N/A | N/A |